Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Spiral Therapeutics is a clinical-stage pharmaceutical company delivering therapies for hearing loss.
Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.
Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.
Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.
Haystack Oncology enables precision oncology to optimize treatment strategies.
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.
Pheast Therapeutics develops checkpoint therapies to harness the innate immune system.
Octant Bio is a developer of synthetic technology used to improve health and treat disease.
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.
Bayesian Health is an adaptive AI platform that offers health systems through clinical AI.
Faze Medicines is a biotechnology company.
Catalio Capital Management has invested in 132 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Catalio Capital Management's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 14 different industry categories.
Among tracked funding rounds, Affini-T Therapeutics received $175.0M in a Series Unknown round. Catalio Capital Management's total known invested capital is $9.5B.
Catalio Capital Management's average investment size is $75.8M across its portfolio of 132 companies.
Recent Catalio Capital Management portfolio additions include Spiral Therapeutics, Georgiamune, Septerna, Perceive Biotherapeutics, Haystack Oncology. These companies were founded in 2020 or later.